Cardiac/Vascular Intervention

Top Story

TRI-REPAIR: Valve reconstruction system reduces tricuspid regurgitation at 1 year

September 17, 2019
In the Journals

Retrospective analysis finds no 5-year mortality risk tied to paclitaxel-coated devices

September 11, 2019
In a retrospective analysis of Japanese patients with peripheral artery disease treated with paclitaxel-coated devices or other devices, paclitaxel-coated devices were…
FDA News

FDA grants breakthrough device designation for coronary intravascular lithotripsy

September 11, 2019
Shockwave Medical announced that the FDA has granted a breakthrough device designation to its intravascular lithotripsy device for the treatment of complex calcified…
Meeting News

DCB bests PTA in patency during treatment of arteriovenous fistula lesions

September 10, 2019
A drug-coated balloon yielded superior patency to percutaneous transluminal angioplasty in patients with de novo or restenotic arteriovenous fistula lesions, according…

Top intervention news of August: TAVR low-risk indications, FDA paclitaxel advisory and more

September 8, 2019
Healio compiled a list of the most-read cardiac and vascular intervention articles in August. This month, our readers were interested in the FDA approval of…
More Headlines »